Plain-English translation of NCT06760169 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the ELIOS laser, a specialized surgical tool designed to treat glaucoma by improving fluid drainage in the eye. The laser creates tiny channels in the eye's drainage system during cataract surgery, which may help lower the pressure inside the eye and slow glaucoma progression. Researchers want to confirm that this treatment is both effective and safe when combined with cataract removal.
Glaucoma damages the optic nerve and can lead to blindness if not treated, but traditional glaucoma surgery can cause serious complications. This laser procedure is less invasive than traditional surgery and may offer patients a safer way to lower eye pressure while also fixing their cataracts in one operation.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo a surgical procedure where the ELIOS laser is used during your cataract surgery to create tiny drainage channels in your eye. The study will track your eye pressure, vision, and any side effects after the procedure to measure how well the treatment works. You will likely have follow-up visits to monitor your healing and long-term results.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France